Hsu, Jer-Yuan
Crawley, Suzanne
Chen, Michael
Ayupova, Dina A.
Lindhout, Darrin A.
Higbee, Jared
Kutach, Alan
Joo, William
Gao, Zhengyu
Fu, Diana
To, Carmen
Mondal, Kalyani
Li, Betty
Kekatpure, Avantika
Wang, Marilyn
Laird, Teresa
Horner, Geoffrey
Chan, Jackie
McEntee, Michele
Lopez, Manuel
Lakshminarasimhan, Damodharan
White, Andre
Wang, Sheng-Ping
Yao, Jun
Yie, Junming
Matern, Hugo
Solloway, Mark
Haldankar, Raj
Parsons, Thomas
Tang, Jie
Shen, Wenyan D.
Alice Chen, Yu
Tian, Hui
Allan, Bernard B.
Article History
Received: 27 May 2017
Accepted: 31 August 2017
First Online: 27 September 2017
Competing interests
: D.L. and A.W. declare no direct competing financial interests. All other authors are or were employees of NGM Biopharmaceuticals or Merck Research Labs and may hold stock or stock options in these companies. NGM Biopharmaceuticals, Inc. has filed a non-provisional patent application entitled “Compositions and Methods for Modulating Body Weight” (PCT/US2017/020753), which discloses the GFRAL–GDF15 protein complex, and methods of identifying agents that may modulate the protein complex interaction(s) and potential uses of those agents to control body weight. J.-Y.H., S.C., J.H., J.T., W.D.S., Y.A.C. and H.T. are listed as inventors.